Join to View Full Profile
5520 Cheviot RdCincinnati, OH 45247
Phone+1 513-451-4033
Fax+1 513-451-4033
Dr. Mehta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2003
SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 2000 - 2002- SUNY Upstate Medical UniversityResidency, Internal Medicine, 1997 - 2000
Seth G.S. Medical CollegeClass of 1991
Certifications & Licensure
OH State Medical License 2002 - 2026
IN State Medical License 1999 - 2013
KY State Medical License 2002 - 2007
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2007 Aug 01
- S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Publications & Presentations
PubMed
- 19 citationsComplete pathologic response rate to neoadjuvant chemotherapy increases with increasing HER2/CEP17 ratio in HER2 overexpressing breast cancer: analysis of the National...Kathriena Greenwell, Lala R. Hussain, David I. Lee, Matthew Bramlage, Gordon Bills
Breast Cancer Research and Treatment. 2020-04-10 - 91 citationsRituximab‐induced interstitial lung diseaseStephanie Wagner, Apurva C. Mehta, Damian A. Laber
American Journal of Hematology. 2007-10-01 - 3 citationsCommon variable immunodeficiency and breast cancer.Apurva C. Mehta, Kathy Faber-Langendoen, David B. Duggan
Cancer Investigation. 2004-02-17
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
